Literature DB >> 11830332

Early induction of nerve growth factor-induced genes after liver resection-reperfusion injury.

Takao Ohkubo1, Yasuhiko Sugawara, Kazuki Sasaki, Kouji Maruyama, Naganari Ohkura, Masatoshi Makuuchi.   

Abstract

BACKGROUND/AIMS: Nur-related factor 1 (Nurr1) has been implicated in liver generation after hepatectomy. We hypothesized that the genes in the nerve growth factor-induced gene B (NGFI-B) family was induced in liver ischemia-reperfusion injury.
METHODS: Expression of the NGFI-B family genes was examined by the reverse transcription-polymerase chain reaction in rat and human livers. In situ hybridization was performed to check the localization of the NGFI-B gene in rat liver. Expression of phospho-Ser-133-specific cyclic adenosine-3' :5'-monophosphate response element binding (pCREB) protein was examined by Western blot analysis and gel shift assay, since the promoter region of the NGFI-B family genes contains CRE.
RESULTS: The expression of the NGFI-B family genes were recognized within 30 min after ischemia-reperfusion in rat liver, which was augmented by cycloheximide injection. In human specimens, the NGFI-B family genes expression was stronger than that before ischemic insult. pCREB protein was detected in the rat liver sampled 15 min after reperfusion. Gel shift assay suggested that CREB bound to neuron-derived orphan receptor gene in rat liver cells.
CONCLUSIONS: We recognized the early induction of the NGFI-B family genes after ischemia-reperfusion injury in rat and human livers. A pathway via CREB may be responsible for the induction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11830332     DOI: 10.1016/s0168-8278(01)00258-6

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  7 in total

1.  Nurr1 promotes intestinal regeneration after ischemia/reperfusion injury by inhibiting the expression of p21 (Waf1/Cip1).

Authors:  Guo Zu; Jihong Yao; Anlong Ji; Shili Ning; Fuwen Luo; Zhenlu Li; Dongcheng Feng; Yiqi Rui; Yang Li; Guangzhi Wang; Xiaofeng Tian
Journal:  J Mol Med (Berl)       Date:  2016-08-24       Impact factor: 4.599

2.  HGF-, EGF-, and dexamethasone-induced gene expression patterns during formation of tissue in hepatic organoid cultures.

Authors:  George K Michalopoulos; William C Bowen; Karen Mulè; Jianhua Luo
Journal:  Gene Expr       Date:  2003

3.  Control of energy balance by hypothalamic gene circuitry involving two nuclear receptors, neuron-derived orphan receptor 1 and glucocorticoid receptor.

Authors:  Sun-Gyun Kim; Bora Lee; Dae-Hwan Kim; Juhee Kim; Seunghee Lee; Soo-Kyung Lee; Jae W Lee
Journal:  Mol Cell Biol       Date:  2013-07-29       Impact factor: 4.272

4.  Up-regulation of nerve growth factor in cholestatic livers and its hepatoprotective role against oxidative stress.

Authors:  Ming-Shian Tsai; Yu-Chun Lin; Cheuk-Kwan Sun; Shih-Che Huang; Po-Huang Lee; Ying-Hsien Kao
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

5.  SMARCB1 Promotes Ubiquitination and Degradation of NR4A3 via Direct Interaction Driven by ROS in Vascular Endothelial Cell Injury.

Authors:  Bingzheng Lu; Zhu Zhu; Longxiang Sheng; Yuan Li; Yang Yang; Yupin Chen; Dongdong Xue; Yuwei Zhou; Wei Cai; Chen Chen; Cailv Wei; Dong Xu; Min Yan; Suizhen Lin; Guangmei Yan; Wei Yin
Journal:  Oxid Med Cell Longev       Date:  2020-10-23       Impact factor: 6.543

Review 6.  NR4A3: A Key Nuclear Receptor in Vascular Biology, Cardiovascular Remodeling, and Beyond.

Authors:  José Martínez-González; Laia Cañes; Judith Alonso; Carme Ballester-Servera; Antonio Rodríguez-Sinovas; Irene Corrales; Cristina Rodríguez
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

7.  miR-381-3p knockdown improves intestinal epithelial proliferation and barrier function after intestinal ischemia/reperfusion injury by targeting nurr1.

Authors:  Liwei Liu; Jihong Yao; Zhenlu Li; Guo Zu; Dongcheng Feng; Yang Li; Wasim Qasim; Su Zhang; Tong Li; Huizhi Zeng; Xiaofeng Tian
Journal:  Cell Death Dis       Date:  2018-03-14       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.